Log in Start free →
Today’s CSR movers
SRE 4.1 ▲ 1.2
ES 3.0 ▲ 0.8
EIX 3.1 ▲ 0.8
AMZN 4.7 ▲ 0.1
GS 2.3 ▼ 0.8
WEC 2.6 ▼ 1.2
ETR 2.9 ▼ 1.2
C 2.8 ▼ 1.2
PCG 2.9 ▼ 1.2
FOX 2.4 ▼ 1.5
—
—
Health Care · NASDAQ NASDAQ · ISRG

Intuitive Surgical

$353.17 +$7.91 +2.24% CLOSE 07.20.26 AFTER HOURS $353.77
Convergence score
4.0 / 5.0 STRONG BULLISH
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$509.78 +44.3%
Range $324.00 — $685.00
Sector
Health Care
NASDAQ · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.20.26
UV Convergence Score
REPORT 07.20.26
4.0
/ 5.0
STRONG BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Rating trend signal
4.3
Analyst average
4.1
Multi-signal aggregate How CSR works →
Day Range
$342.10 – $355.08
52W Range
$342.10 – $603.88
Volume
5.7M
Avg Vol
2.8M
Mkt Cap
$125.08B
P/E
40.59
EPS (TTM)
$8.70
Div Yield
—
Beta
1.46
Today's convergence

Convergence score sits at 4.0 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
STRONG BULLISH
Last close
$353.17
Sector
Health Care
Valuation
Three horizons
UPDATED 07.20.26
Short term
0–3 MO
No target Moderate Buy
Medium term
3–12 MO
$523+48.2% Buy
Long term
12–36 MO
$173.78-50.8% Overvalued
Open valuation →
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$509.78 +44.3%
RANGE $324.00 — $685.00
Analyst consensus
Consensus rating Buy
Blended score 4.1 / 5
Analysts tracked 122
Open analysts →
Financials
Key metrics
LATEST
P/E
40.59
EPS (TTM)
$8.70
Mkt Cap
$125.08B
Div Yield
—
Beta
1.46
52W Range
$342.10 – $603.88
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26
Short term
0–3 MO
Moderate Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Buy
Consensus target
$523 +48.2%
RANGE $366 – $685
$366NOW $353.17$685

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$173.78 -50.8%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 40.59PEG Ratio: -DE Ratio: -
Free Cash Flow: -PB Ratio: -PS Ratio: -Dividend: -
Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.20.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Buy 4.1 4 122
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $324.00 $509.78 $500.00 $685.00 +44.3%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 6 37 17 2 0
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current Moderate Buy 4.29 31
1 Mo Ago Moderate Buy 4.27 30
2 Mo Ago Moderate Buy 4.27 30
3 Mo Ago Moderate Buy 4.27 30
Most recent analyst action LATEST DESK ACTION
Date
7/17/2026
Firm
Raymond James Financial
Action
Reiterated Rating
Rating
Outperform
Target
$483.00
Related links
Financials

Full financial snapshot.

UPDATED 07.20.26
Quote snapshot 15 FIELDS
Prev Close
$345.42
Open
$346.77
Day Low
$342.10
Day High
$355.08
Bid
$353.96
Ask
$355.00
52W Low
$342.10
52W High
$603.88
50D Avg
$416.97
200D Avg
$486.56
Volume
5.7M
Avg Vol
2.8M
10D Avg Vol
4.0M
52W Change
-33.07%
S&P 52W Change
18.27%
Valuation ratios 10 FIELDS
P/E (TTM)
40.59
P/E (Fwd)
29.42
PEG (Fwd)
1.81
P/S
11.34
P/B
7.16
Book Value
$49.31
EV/Revenue
10.55
EV/EBITDA
27.93
Mkt Cap
125.08B
Enterprise Val
116.43B
Profitability & returns 6 FIELDS
Profit Margin
28.45%
Gross Margin
66.77%
Operating Margin
33.74%
EBITDA Margin
37.78%
Return on Assets
10.54%
Return on Equity
17.42%
Growth 3 FIELDS
Revenue Growth (YoY)
18.50%
Earnings Growth (YoY)
26.50%
Earnings Growth (Q)
24.30%
Balance sheet & cash flow 11 FIELDS
Total Revenue
11.03B
EBITDA
4.17B
Total Cash
8.63B
Total Debt
—
Cash / Share
$24.36
Revenue / Share
$31.07
Free Cash Flow
—
Operating CF
—
Debt / Equity
—
Current Ratio
6.43
Quick Ratio
5.37
Dividend 5 FIELDS
Fwd Dividend
—
Dividend Yield
—
Payout Ratio
0.00%
5Y Avg Yield
—
Ex-Div Date
—
Share statistics 7 FIELDS
Shares Out
354.16M
Float
352.03M
Shares Short
7.32M
% Short of Float
2.08%
Short Ratio
2.79
% Held Insiders
0.51%
% Held Institutions
90.44%
Calendar & events 5 FIELDS
Next Earnings
2026-10-20
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-06-30
Last Split
3:1
Split Date
2021-10-05
Company 2 FIELDS
Industry
Medical Instruments & Supplies
Employees
17,021